Refine by
Clinical Program Suppliers Serving Iceland
81 companies found
based inWest Lafayette, INDIANA (USA)
Tymora Analytical Operations provides diagnostic development and exosome proteomics contract services and products for improved cancer research. Tymora’s primary goal is to enable the shift from tissue to liquid biopsy. Our new technologies allow ...
based inIrvine, CALIFORNIA (USA)
JenaValve is a clinical-stage medical device company developing the first transcatheter heart valve technology that is uniquely designed for the minimally invasive treatment of both severe aortic regurgitation and stenosis. JenaValve is passionate ...
based inFremont, CALIFORNIA (USA)
AlterG develops trusted, leading-edge rehab and training equipment using NASA Differential Air Pressure technology. Our Anti-Gravity Treadmill™ technology empowers people to move in new ways and without pain – to recover mobility, improve wellness, ...
Remove barriers for your patients and advance your clinic with the AlterG® Anti-Gravity Treadmill™ system for physical therapy and rehabilitation. Leading the way in Anti-Gravity Treadmill™ technology since 2005, AlterG® uses ...
based inShanghai, CHINA
Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation immunotherapies to benefit cancer patients worldwide. Elpiscience has a robust pipeline of globally innovative cancer immunotherapies covering a wide ...
based inKawaguchi City, Saitama, JAPAN
Since our founding in 1916, alongside its own research and development, ITO has sought out and adopted technologies from around the world to design numerous physiotherapy devices. Drawing on this legacy, we launched full-fledged international ...
High-end Combination Unit with 5 Independent Channels and Body Diagram ...
based inPortsmouth, NEW HAMPSHIRE (USA)
Laborie is a global medical technology company specializing in Gastroenterology, Urology & Urogynecology, and Obstetrics, Gynecology & Neonatal. As we grow our business and expand our product offering, we may move into more medical segments and new ...
based inCambridge, MASSACHUSETTS (USA)
Myeloid Therapeutics is a leader in the development of mRNA-based immunotherapies, focusing on harnessing and enhancing the natural capabilities of myeloid cells to combat cancer. The company's cutting-edge in vivo engineering platform is designed ...
MT-303 represents the first candidate in a new therapeutic modality targeting hepatocellular carcinoma (HCC). Liver cancer is a prevalent and challenging cancer with over 850,000 new cases diagnosed globally each year, and the third leading cause of ...
based inCopenhagen V, DENMARK
Founded in 1999 in Copenhagen, Denmark, we are a dual-listed, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. We are led by an experienced ...
based inTempe, ARIZONA (USA)
Align Technology is a global medical device company that is changing lives through better smiles. We reimagine and reinvent the way orthodontic and restorative treatment is presented and delivered to millions of people around the world. We believe a ...
The Invisalign system is the most advanced clear aligner system in the world. Backed by two decades of innovation, the Invisalign system has helped bring smiles to over 9.6 million people including over 2.4 million ...
based inBothell, WASHINGTON (USA)
Cerevast Medical, Inc. is a clinical-stage medical device company based in Bothell, Washington, USA. Leveraging our core expertise in the fields of ultrasound and microsphere technologies, we are committed to developing novel, first-in-class ...
based inMinsk Region, BELARUS
Medindustria Service Ltd is a modern, high-tech, dynamically developing company, which occupies one of the leading positions among the world's manufacturers of medical equipment and furniture. We implement time-tested and new technical ideas aimed ...
based inMilpitas, CALIFORNIA (USA)
Elixir Medical is committed to transforming care of patients with heart and vascular disease through innovation. Since 2005, the company has continually sought to improve the treatment of vascular disease with: Drug-eluting coronary stent systems ...
Novolimus is a metabolite of the drug Sirolimus, a novel mTOR inhibitor macrolytic lactone with anti-proliferative and anti-inflammatory properties developed by Elixir Medical. The macrocyclic lactone drugs represent the most widely utilized drug ...
based inBoca Raton, FLORIDA (USA)
Entero Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing targeted, orally delivered therapies for gastrointestinal (GI) diseases. At the core of its research are three proprietary technologies. Latiglutenase is an ...
Latiglutenase, known as IMGX003, is an orally administered formulation comprising two recombinant proteases specifically targeting gluten proteins. It works by breaking down these proteins into smaller, non-reactive fragments, offering an adjunctive ...
based inAllendale, NEW JERSEY (USA)
We are a leading global contract development and manufacturing organization (CDMO) dedicated to the advancement and manufacturing of gene and cell therapy products. Minaris Regenerative Medicine is a leading global contract development and ...
Regardless of the type of cell therapy product or the medical indication, the production of cell-based therapeutics is highly complex. Minaris Regenerative Medicine offers you comprehensive manufacturing experience, fully compliant with the relevant ...
based in, CHINA
Medarchitect is a company specializing in the design, development and manufacture of medical simulation, and are committed to providing high-quality simulation training tools that are close to real scenarios for medical learners and educational ...
The Medarchitect Suture Practice Arm is ideal for hand surgical suture training. Made of high-quality silicone, this Suturing Training Hand Model features realistic textures—including wrinkles, pores, and visible fingerprints. The skin is soft ...
based inCoral Gables, FLORIDA (USA)
We are a late-stage biotech company addressing diseases of the central nervous system (CNS), with a focus on major depressive disorder (MDD). Our experienced and dedicated team is committed to making a difference in the lives of patients and their ...
Novel MOA: REL-1017 works as an NMDAR channel blocker with preferential activity at hyperactive GluN1-GluN2D channels. REL-1017 is a novel N-methyl-D-aspartate receptor (NMDAR) channel blocker in phase 3 clinical trials for the treatment of Major ...
based inBrunswick, AUSTRALIA
Avania is an integrated global, full-service CRO with specialized expertise in medical device, novel technology, and combination products. They advance products from feasibility all the way through post-approval trials in analytics, clinical trials, ...
Your clinical trial success depends upon the quality and integrity of the data you collect. Avania provides customized data management systems to meet the specific needs of your study. Make better business decisions through easy access to real-time ...
based inGeneva, SWITZERLAND
Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available, small molecule drugs known as allosteric modulators for neurological disorders. Allosteric ...
We are developing mGlu2 NAM as a novel orally available treatment for mNCD associated with Alzheimer’s disease, Parkinson’s disease and depressive disorders. The program is in clinical candidate ...
based inMountain View, CALIFORNIA (USA)
IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. We ...
based inLaval, QUEBEC (CANADA)
Biodextris is comprised of experienced product development scientists located in Laval (Montreal), Quebec. The Biodextris Team has worked together in mid and large sized vaccine companies for the past 18 years, now offering our big pharma expertise ...